Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Feb;7(2):e1967.
doi: 10.1002/cnr2.1967. Epub 2023 Dec 26.

Cancer incidence in Iran in 2016: A study based on the Iranian National Cancer Registry

Fatemeh Hadavandsiri  1 , Leila Allahqoli  2 , Yekta Rahimi  3 , Hamid Salehiniya  4 , Ehsan Ghazanfari Savadkoohi  5 , Mohammad Esmaeil Akbari  1
Affiliations
Review

Cancer incidence in Iran in 2016: A study based on the Iranian National Cancer Registry

Fatemeh Hadavandsiri et al. Cancer Rep (Hoboken). 2024 Feb.

Abstract

Background: Cancer poses an escalating public health challenge, necessitating a comprehensive understanding of cancer incidence to formulate effective control strategies.

Aims: This study aims to present a comprehensive overview of cancer incidence in Iran, utilizing data from the Iranian National Population-based Cancer Registry (INPCR) for the year 2016.

Methods: The study employed INPCR data to compute crude and age-standardized incidence rates (ASR) per 100 000 for the most common cancers among men and women across Iran's 31 provinces. Data analysis utilized Excel (2019) and STATA 14.

Results: In 2016, 124 833 new cancer cases were registered, with 65 495 (52.90%) occurring in men and 58 312 (47.10%) in women. ASRs for all cancers in the total population were 177.48, with specific rates for men and women at 192.96 and 162.33, respectively. The five most common cancers in men were prostate (23.25), stomach (21.56), colon (19.30), bladder (16.20), and lung (13.15). Among women, the leading cancers were breast (40.60), colon (14.64), thyroid (10.84), stomach (10.25), and lung (5.63). West Azarbaijan had the highest incidence among men, while Yazd topped the list for women. Age-specific incidence rates revealed peaks in the 67-74 age group for men and the 40-50 age group for women.

Conclusion: This study affirms that while Iran exhibits a lower cancer incidence compared to global averages, there has been a temporal increase. Disparities in ASR exist across sexes and provinces, with shifts in the ranking of common cancers by sex compared to previous reports.

Keywords: Iran; cancer; cancer registry; incidence.

PubMed Disclaimer

Conflict of interest statement

The authors have stated explicitly that there are no conflicts of interest in connection with this article.

Figures

FIGURE 1
FIGURE 1
Five most common age‐specific cancer incidence rates (per 100 000) in Iran, 2016 (women).
FIGURE 2
FIGURE 2
Five most common age‐specific cancer incidence rates (per 100 000) in Iran, 2016 (men).
See this image and copyright information in PMC

References

    1. Quaresma M, Coleman MP, Rachet B. 40‐year trends in an index of survival for all cancers combined and survival adjusted for age and sex for each cancer in England and Wales, 1971‐2011: a population‐based study. Lancet (London, England). 2015;385(9974):1206‐1218. - PubMed
    1. Collaboration GBoDC . Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability‐adjusted life‐years for 29 cancer groups, 1990 to 2016: a systematic analysis for the global burden of disease study. JAMA Oncol. 2018;4(11):1553‐1568. - PMC - PubMed
    1. Dolatkhah R, Somi MH, Kermani IA, et al. Increased colorectal cancer incidence in Iran: a systematic review and meta‐analysis. BMC Public Health. 2015;15:997. - PMC - PubMed
    1. Ferlay J, Ervik M, Lam F, et al. Global Cancer Observatory: Cancer Today. International Agency for Research on Cancer; 2018. Accessed 4/02/2021. https://gco.iarc.fr/today
    1. Mousavi SM, Gouya MM, Ramazani R, Davanlou M, Hajsadeghi N, Seddighi Z. Cancer incidence and mortality in Iran. Ann Oncol. 2009;20(3):556‐563. - PubMed